Literature DB >> 8114716

Frameshift mutations in the v-src gene of avian sarcoma virus act in cis to specifically reduce v-src mRNA levels.

S B Simpson1, C M Stoltzfus.   

Abstract

A portion of the avian sarcoma virus (ASV) primary RNA transcripts is alternatively spliced in chicken embryo fibroblast cells to two different messages, the src and env mRNAs. Frameshift mutations of the viral genome causing premature translation termination within the src gene result in a decreased steady-state level of the src mRNA. In marked contrast, frameshift mutations at various positions of the env gene do not decrease the level of the env mRNA. We show that the src gene product is not required in trans for splicing and accumulation of src mRNA. Conversely, the truncated Src proteins do not act negatively in trans to decrease specifically the levels of src mRNA. Taken together, these results indicate that the frameshift mutations act in cis to reduce src mRNA levels. A double mutant with a lesion in the src initiator AUG and a frameshift within the src gene demonstrated wild-type RNA levels, indicating that the src mRNA must be recognized as a translatable mRNA for the effect on src mRNA levels to occur. Our results indicate that the reduced levels do not result from decreased cytoplasmic stability of the mature src mRNA. We also show that the src gene frameshift mutations affect src mRNA levels when expressed from intronless src cDNA clones. We conclude that the reduction of src mRNA levels triggered by the presence of frameshift mutations within the src gene occurs while it is associated with the nucleus. Our data also strongly suggest that this occurs at a step of RNA processing or transport independent of RNA splicing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114716      PMCID: PMC358541          DOI: 10.1128/mcb.14.3.1835-1844.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  25 in total

1.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  mRNA destabilization triggered by premature translational termination depends on at least three cis-acting sequence elements and one trans-acting factor.

Authors:  S W Peltz; A H Brown; A Jacobson
Journal:  Genes Dev       Date:  1993-09       Impact factor: 11.361

4.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

5.  Beta O-39 thalassemia gene: a premature termination codon causes beta-mRNA deficiency without affecting cytoplasmic beta-mRNA stability.

Authors:  R K Humphries; T J Ley; N P Anagnou; A W Baur; A W Nienhuis
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

6.  Avian sarcoma virus gag and env gene structural protein precursors contain a common amino-terminal sequence.

Authors:  T A Ficht; L J Chang; C M Stoltzfus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Identification of an amino terminal domain required for the transforming activity of the Rous sarcoma virus src protein.

Authors:  V W Raymond; J T Parsons
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

8.  Interference of nonsense mutations with eukaryotic messenger RNA stability.

Authors:  R Losson; F Lacroute
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  Regulation of Rous sarcoma virus RNA splicing and stability.

Authors:  S Arrigo; K Beemon
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

10.  Transduction of a cellular oncogene: the genesis of Rous sarcoma virus.

Authors:  R Swanstrom; R C Parker; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  25 in total

Review 1.  mRNA surveillance in eukaryotes: kinetic proofreading of proper translation termination as assessed by mRNP domain organization?

Authors:  P Hilleren; R Parker
Journal:  RNA       Date:  1999-06       Impact factor: 4.942

2.  A premature termination codon interferes with the nuclear function of an exon splicing enhancer in an open reading frame-dependent manner.

Authors:  A Gersappe; D J Pintel
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

3.  RNA surveillance down-regulates expression of nonfunctional kappa alleles and detects premature termination within the last kappa exon.

Authors:  Laurent Delpy; Christophe Sirac; Emmanuelle Magnoux; Sophie Duchez; Michel Cogné
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

4.  Binary specification of nonsense codons by splicing and cytoplasmic translation.

Authors:  R Thermann; G Neu-Yilik; A Deters; U Frede; K Wehr; C Hagemeier; M W Hentze; A E Kulozik
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

5.  Molecular events accompanying rous sarcoma virus rescue from rodent cells and the role of viral gene complementation.

Authors:  Anna Lounková; Eduarda Dráberová; Filip Šenigl; Katerina Trejbalová; Josef Geryk; Jirí Hejnar; Jan Svoboda
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

6.  Defects in RNA splicing and the consequence of shortened translational reading frames.

Authors:  L E Maquat
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

7.  A splicing-dependent regulatory mechanism that detects translation signals.

Authors:  M S Carter; S Li; M F Wilkinson
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

8.  Mammalian nonsense codons can be cis effectors of nuclear mRNA half-life.

Authors:  P Belgrader; J Cheng; X Zhou; L S Stephenson; L E Maquat
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Studies of the expression of the Wiskott-Aldrich syndrome protein.

Authors:  D M Stewart; S Treiber-Held; C C Kurman; F Facchetti; L D Notarangelo; D L Nelson
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Structural features in the Rous sarcoma virus RNA stability element are necessary for sensing the correct termination codon.

Authors:  Johanna B Withers; Karen L Beemon
Journal:  Retrovirology       Date:  2010-08-05       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.